Catheter ablation is one of the fastest growing service lines in U.S. healthcare. More and more patients are diagnosed with atrial fibrillation (AFib) and similar conditions, and electrophysiology (EP) labs are treating them as fast as they can diagnose them.
Improvements in catheter ablation technology and methodology are not only having a great impact on patients and their quality of life, but are also making a mark financially: A new economic analysis estimates that $2.5 billion will be spent in 2020 on medical devices used for catheter ablation. At the level of the individual procedure, an AFib procedure absorbs about $10,500 in medical device costs alone…
Read the full article HERE